Internal Medicine

Lipid Disorders

Questions discussed in this category

For a patient with known CAD and low baseline HDL, would a PCSK9 inhibitor be a better option than a statin, given concerns for paradoxical lowering of HDL levels with statin therapy that we can encounter in the outpatient clinical setting?

5 Answers available

Related Topics in Internal Medicine